that depends on what their plan isif they have acquisitions in...

First 15 Last

Share
Profile

Follow
MAUOMBO

1,886 Posts.

35

13/02/19

15:37

Post #: 37425306
Share

Originally posted by joewolf: ↑

No need for a CR at All. The had $19 million cash and cash equivalents at 30 June and raised $5 million in July which looked like they didn't need it but wanted Sargon on board.

They have not been running down cash over the past couple of years.

Really lets logically look at where they are:

Ex CEO has around 11 million shares , probably cannot sell as he would have been privy to performance until a week ago. So probably in a closed period. It really depends on him - I wont buy right now because is this a bargain price or may the overhang keep the share moving down and I am not privy to the half year. So I am waiting for information.

If he holds, few actually do after a disagreement. So I expect that there is a large pool of shares looking for a home at some point.

So effectively I am waiting for things to unfold and I expect many holders here are doing just the same.

I would also have liked to see John Larson remain on the board as well. I think he is a great asset to the company.

I am also not a lover of the stockbroking side so want to see that unfold as well. So too many moving parts.

Expand

that depends on what their plan is

if they have acquisitions in mind, a raising might be needed. What other reasons to use small transactions to push price down?

[possible: to keep price low in case SB is going to sell, and someone wants to soak them up cheaply]

SEQ Price at posting: 26.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

SHN

Chimeric clocks $4.17M R&D tax rebate from Canberra

Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MTM

Australian Rare Earths bullish on early-stage uranium potential at Overland, SA

OCN

Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke

Chaos reigns markets – so let's take stock of where we're at ahead of December

PME

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

There are more pages in this discussion • 6 more messages in this thread...

First 15 Last

Add SEQ (ASX) to my watchlist

(20min delay)
Last 34.0¢		Change 0.000(0.00%)		Mkt cap ! $48.48M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	50000	33.0¢

Sellers (Offers)

Price($)	Vol.	No.
34.5¢	29697	1

View Market Depth

No.	Vol.	Price($)
1	29291	0.240
1	96902	0.235
1	25000	0.225
1	14191	0.210
1	5000	0.200

Price($)	Vol.	No.
0.255	7487	1
0.270	30000	1
0.275	70000	1
0.295	16666	1
0.300	450000	2

Last trade - 16.16pm 29/11/2024 (20 minute delay)

SEQ (ASX) Chart

that depends on what their plan isif they have acquisitions in...

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Chimeric clocks $4.17M R&D tax rebate from Canberra

Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Australian Rare Earths bullish on early-stage uranium potential at Overland, SA

Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke

Chaos reigns markets – so let's take stock of where we're at ahead of December

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Buyers (Bids)

Sellers (Offers)